Miruvor
Sign up
The short answer

What studies of antimicrobial botanicals (other) found

3papers on antimicrobial botanicals (other)
1 (few people)person in 1 study testing antimicrobial botanicals (other) alone
0randomised trials, the strongest kind of study

At a glance, by condition

ME/CFS: C Might help, very uncertain

Based on the strongest evidence, studies with no comparison group (very low certainty): 3 findings, all C.

3 outcomes rated · see each below

How we got this

Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.

What this means: Antimicrobial botanicals (other) might help some people with ME/CFS, but research can’t show it yet. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.

Ask about this treatment

Sign up free to read the rest of what studies found.

You’ll see the full picture: how each symptom fared, every grade with its reasons, side effects and all 3 papers.

The grades, in plain words

Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.

  1. A
    HelpsImprovement, high certainty
    Probably helpsImprovement, moderate certainty
  2. B
    May helpImprovement, low certainty
  3. Antimicrobial botanicals (other) · ME/CFS is hereC
    Might help, very uncertainImprovement, very low certainty
    Mixed resultsStudies disagree
  4. D
    Little or no differenceStudies found little or no difference
  5. F
    HarmsIt made things worse

By symptom and daily life

ME/CFS

Symptoms

Breathlessness1 study · 1 (few people) person took antimicrobial botanicals (other) Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.

Studies with no comparison group1 in the study · 2010 to 2026 · started in July 2019; daily (few people)

Breathlessness improved.

The evidence is very uncertain about the effect of antimicrobial botanicals (other) on breathlessness in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (1 in all)
  • Not all results were tested against chance
See the 1 study
  1. Home Alone 2020: A First-Person Case Study on Surviving Modern Pandemics and their Aftermath of Illnesses (2026)

    People in the study
    1 in the study
    Dose
    started in July 2019; daily
    Outcome
    not blue-purple or breathless
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I

Daily life and health overall

Daily functioning1 study · 1 (few people) person took antimicrobial botanicals (other) Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.

Studies with no comparison group1 in the study · 2010 to 2026 · started in July 2019; daily (few people)

Daily functioning improved.

The evidence is very uncertain about the effect of antimicrobial botanicals (other) on daily functioning in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (1 in all)
  • Not all results were tested against chance

Combination: Levothyroxine (Synthroid) + Natural desiccated thyroid (Armour, NP Thyroid) + Doxycycline (Vibramycin) + Nystatin + a different antibiotic + Succinic acid + NAC (N-acetylcysteine) + Bromelain + a liver detox blend + Antibiotics (unspecified) + Gentamicin + Hydroxychloroquine / Plaquenil + Dipyridamole (Persantine) + Lactoferrin and colostrum + Astragalus + Andrographis + AHCC and medicinal mushrooms (reishi, shiitake, maitake) + Fluconazole (Diflucan) + Kelp + Ashwagandha + Eleuthero (Siberian ginseng) + Licorice and glycyrrhizin + Fludrocortisone / Florinef + Trauma work (EFT, EMDR, TRE) + light therapy + Inosine + PABA (para-aminobenzoic acid) + DMAE + Lyme / co-infection protocols + Colloidal silver + Olive leaf extract + Antimicrobial botanicals (other) + Neem1 in the study

Chronic Fatigue Syndrome: A Case Report Highlighting Diagnosing and Treatment Challenges and the Possibility of Jarisch-Herxheimer Reactions If High Infectious Loads Are Present. (2021): return to graduate school, better (not tested).

Shown, not counted: antimicrobial botanicals (other) was given together with other treatments.

See the 1 study
  1. Home Alone 2020: A First-Person Case Study on Surviving Modern Pandemics and their Aftermath of Illnesses (2026)

    People in the study
    1 in the study
    Dose
    started in July 2019; daily
    Outcome
    wore a dress reserved for swim days only
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Overall symptoms1 study · 1 (few people) person took antimicrobial botanicals (other) Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.

Studies with no comparison group1 in the study · 2010 to 2026 · started in July 2019; daily (few people)

Overall symptoms improved.

The evidence is very uncertain about the effect of antimicrobial botanicals (other) on overall symptoms in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (1 in all)
  • Not all results were tested against chance
See the 1 study
  1. Home Alone 2020: A First-Person Case Study on Surviving Modern Pandemics and their Aftermath of Illnesses (2026)

    People in the study
    1 in the study
    Dose
    started in July 2019; daily
    Outcome
    brief and remarkable reprieve
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I

Studies of combinations

Outcomes that only studies of antimicrobial botanicals (other) given together with other treatments looked at. Shown, not graded: they can’t tell what antimicrobial botanicals (other) did alone.

Cognition (brain fog) ME/CFS

Combination: Levothyroxine (Synthroid) + Natural desiccated thyroid (Armour, NP Thyroid) + Doxycycline (Vibramycin) + Nystatin + a different antibiotic + Succinic acid + NAC (N-acetylcysteine) + Bromelain + a liver detox blend + Antibiotics (unspecified) + Gentamicin + Hydroxychloroquine / Plaquenil + Dipyridamole (Persantine) + Lactoferrin and colostrum + Astragalus + Andrographis + AHCC and medicinal mushrooms (reishi, shiitake, maitake) + Fluconazole (Diflucan) + Kelp + Ashwagandha + Eleuthero (Siberian ginseng) + Licorice and glycyrrhizin + Fludrocortisone / Florinef + Trauma work (EFT, EMDR, TRE) + light therapy + Inosine + PABA (para-aminobenzoic acid) + DMAE + Lyme / co-infection protocols + Colloidal silver + Olive leaf extract + Antimicrobial botanicals (other) + Neem1 in the study

Chronic Fatigue Syndrome: A Case Report Highlighting Diagnosing and Treatment Challenges and the Possibility of Jarisch-Herxheimer Reactions If High Infectious Loads Are Present. (2021): doing better cognitively, better (not tested).

Shown, not counted: antimicrobial botanicals (other) was given together with other treatments.

Side effects

No study of this treatment alone reported side effects we could read.

All papers

  1. Home Alone 2020: A First-Person Case Study on Surviving Modern Pandemics and their Aftermath of Illnesses2026 · case report · 1 in the study
    Summary

    This single-person case study reports the author’s ME/CFS course from 2010 to 2026, with no comparison group and no blinding. Treatments included Valtrex (valacyclovir) eight tablets a day throughout 2016; Xue-Fu-Zhu-Yu-Tang; weekly acupuncture for eighteen months; Lomatium dissectum started in July 2019 and taken daily; Oxymatrine (or Equilibrant); X39 phototherapy patches since summer 2020; concentrated oxygen ninety minutes a day over six months; and xylitol nasal spray since winter 2020. The author reports using laboratory results and her own observations, not a validated symptom scale. After only two weeks of Chinese herbs she had a brief and remarkable reprieve. After six weeks of acupuncture she went, in her case, from being bedridden and dying to dancing; after six months of weekly acupuncture she survived a short flight and reported dancing like a twenty year old. Weekly acupuncture over eighteen months revived her, but did not kill the viruses. Lomatium produced an immediate emotional response called a pathogen “die-off” and left her feeling lighter in body and spirit. Patches restored energy; concentrated oxygen coincided with improvements in pre-diabetes, allergies, arthrosis and breathing. Valtrex viral loads never dropped, and eight tablets a day made her very ill. Harms included not tolerating certain herbs or tablets and medication overload, elimination and withdrawal; she never had the Lomatium rash. The authors state the case cannot show causation.

  2. P05.07. Chronic Fatigue, Depression, and Sleep Disturbances in a 20-year-old Male Collegiate Basketball Player: A Case Report2013 · case report · 1 in the study
    Summary

    This conference abstract reports a case report of one 20-year-old male collegiate basketball player with chronic fatigue, depression, and abnormal sleep patterns; he was diagnosed with chronic fatigue syndrome and overtraining syndrome by a specialty physician group. At his initial visit to a chiropractic physician specializing in functional medicine, functional testing reportedly showed adrenal syndrome, Helicobacter pylori, Giardia, Entamoeba histolytica, and Cryptosporidium parvum infections, lead and mercury toxicity, and abnormal amino acid levels on organic cation transporter status. The patient was given recommended specific dosages of DHEA, licorice root, and pregnenlone to reduce adrenal syndrome; botanical antimicrobial and antiparasitic supplementation; additional nutrients and silymarin; and a protocol of 5-HTP and tyrosine. He also changed to an ancestral diet and was recommended a core multivitamin, antioxidant, and essential fatty acid supplementation, with other personalized recommendations based on functional labs. Treatment duration was not reported. There was no comparison group and no randomisation. After treatment, the patient experienced restoration of normal sleep patterns and elimination of his depression and chronic fatigue, and was able to exercise and maintain a normal lifestyle. Harms and withdrawals were not reported. The authors concluded that uncommon patient populations can suffer chronic fatigue secondary to subclinical infections regardless of apparent health status and that functional analysis of adrenal, gastrointestinal, and detoxification organ systems can assist in complex cases. They did not report limitations.

  3. Chronic Fatigue Syndrome: A Case Report Highlighting Diagnosing and Treatment Challenges and the Possibility of Jarisch-Herxheimer Reactions If High Infectious Loads Are Present.2021 · combination: given with other treatments · 1 in the study
    Summary

    This case report described one patient with severe ME/CFS who presented to a rheumatologist’s office in August 2013 after becoming bedridden 4.5 years earlier. Over a 4-year period from September 2013 to August 2017, the patient received a changing protocol that included thyroid medications, antibiotics, antifungals, Hydroxychloroquine, colostrum, kelp, licorice root, fludrocortisone, EFT, EMDR, light therapy, and multiple herbs and supplements. No comparison group was reported. The report described function and symptoms over time. By the Spring of 2014 (~6 months after onset of treatment), she had improved enough to take a college course 1 day/week but was not well enough to drive. By February 2015 she was still predominantly housebound; she was doing better cognitively, but simple activity like walking was still too difficult on most days. She was back at the gym by April 2017 and going for walks daily. In August 2017 she was well enough to move out from her parents’ home and resume graduate school, and she had been stable for at least 6 months. Reported harms included Jarisch–Herxheimer reactions with severe joint and musculoskeletal pain, worsening fatigue, worsening cognitive function, migraines, and drops in blood pressure; doxycycline was discontinued. She also had severe reactions from all supplements, severe discomfort during EFT/EMDR sessions, and could not tolerate blue light more than 1–2 min without severe migraines. The authors stated it was not possible to determine whether improvements were mediated by treatments or spontaneous remission/placebo.

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime